Literature DB >> 21499772

Concomitant thrombotic thrombocytopenic purpura and ANCA-associated vasculitis in an adolescent.

Varun Agrawal1, Chirag K Vaidya, Jiuming Ye, Jonathan Freeman, Christine McKiernan, Peter R Blier, Chester Andrzejewski, Michael Germain, Gregory L Braden.   

Abstract

Thrombotic thrombocytopenic purpura (TTP) rarely occurs with systemic vasculitis. A 17-year-old girl presented with non-bloody diarrhea, menorrhagia, and syncope. She had severe anemia (hemoglobin = 3.8 g/dl), thrombocytopenia (platelet = 7,000/mm(3)), and acute kidney injury (serum creatinine, Cr = 2.3 mg%). Peripheral smear examination confirmed the presence of microangiopathic hemolytic anemia. Additionally, she had a positive anti-nuclear antibody (1:1600) and normal complement levels. We considered the diagnosis of TTP, possibly associated with systemic lupus erythematosus, and promptly initiated pulse methylprednisolone and daily 3-4 l of plasma exchange therapy. Following resolution of her thrombocytopenia in 48 h, we performed a kidney biopsy that revealed diffuse proliferative, focal crescentic, and necrotizing glomerulonephritis with mild IgG immunofluorescence staining. Concomitantly, autoimmune work-up was significant for positive perinuclear anti-neutrophil cytoplasmic antibodies (p-ANCA = 1:640) and decreased von Willebrand factor cleaving protease activity (<5%). A final diagnosis of TTP with microscopic polyangiitis (p-ANCA-mediated) was made and treatment with daily oral cyclophosphamide and prednisone resolved her renal injury over 2 months (follow-up Cr = 1.0 mg%). Our case highlights the importance of identifying systemic disorders such as ANCA-associated vasculitis with TTP.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21499772     DOI: 10.1007/s00467-011-1862-5

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  15 in total

1.  Successful treatment with rituximab in a patient with TTP secondary to severe ANCA-associated vasculitis.

Authors:  Yukari Asamiya; Takahito Moriyama; Mari Takano; Chihiro Iwasaki; Kazuo Kimura; Yukako Ando; Akiko Aoki; Kan Kikuchi; Takashi Takei; Keiko Uchida; Kosaku Nitta
Journal:  Intern Med       Date:  2010-08-02       Impact factor: 1.271

2.  Vascular damage in Wegener's granulomatosis and microscopic polyarteritis: presence of anti-endothelial cell antibodies and their relation to anti-neutrophil cytoplasm antibodies.

Authors:  C O Savage; B E Pottinger; G Gaskin; C M Lockwood; C D Pusey; J D Pearson
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

3.  Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis and thrombotic microangiopathy.

Authors:  D J Hirsch; K K Jindal; A A Trillo
Journal:  Am J Kidney Dis       Date:  1995-08       Impact factor: 8.860

4.  A patient with SLE-associated thrombotic microangiopathy and non-neutralizing antibodies against ADAMTS13.

Authors:  Margrith E Knecht; Michael Mayr; Silvia Ferrari; Friedrich Scheiflinger; Marten Trendelenburg
Journal:  Nephrol Dial Transplant       Date:  2010-01-28       Impact factor: 5.992

5.  Elevated platelet-associated IgG in thrombotic thrombocytopenic purpura.

Authors:  J Morrison; R McMillan
Journal:  JAMA       Date:  1977-10-31       Impact factor: 56.272

6.  Two novel ADAMTS13 gene mutations in thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome (TTP/HUS).

Authors:  Christoph Licht; Ludwig Stapenhorst; Thorsten Simon; Ulrich Budde; Reinhard Schneppenheim; Bernd Hoppe
Journal:  Kidney Int       Date:  2004-09       Impact factor: 10.612

Review 7.  Vasculitides associated with IgG antineutrophil cytoplasmic autoantibodies in childhood.

Authors:  Federica Vanoni; Alberto Bettinelli; Franco Keller; Mario G Bianchetti; Giacomo D Simonetti
Journal:  Pediatr Nephrol       Date:  2009-07-30       Impact factor: 3.714

8.  Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis.

Authors:  Renate Kain; Markus Exner; Ricarda Brandes; Reinhard Ziebermayr; Dawn Cunningham; Carol A Alderson; Agnes Davidovits; Ingrid Raab; Renate Jahn; Oliver Ashour; Susanne Spitzauer; Gere Sunder-Plassmann; Minoru Fukuda; Per Klemm; Andrew J Rees; Dontscho Kerjaschki
Journal:  Nat Med       Date:  2008-10-05       Impact factor: 53.440

9.  Successful treatment of thrombotic thrombocytopenic purpura with repeated plasma exchange in a patient with microscopic polyangitis.

Authors:  Koji Nagai; Takuya Kotani; Tohru Takeuchi; Takeshi Shoda; Ayu Hata-Kobayashi; Daisuke Wakura; Maki Kagitani; Shigeki Makino; Toshiaki Hanafusa
Journal:  Mod Rheumatol       Date:  2008-09-02       Impact factor: 3.023

10.  Successful treatment for thrombotic thrombocytopenic purpura complicated with myeloperoxidase anti-neutrophil cytoplasmic autoantibody-associated vasculitis.

Authors:  Yoko Yamauchi; Katsuyuki Nagatoya; Ayako Okuno; Naohiko Fujii; Toru Inoue
Journal:  NDT Plus       Date:  2010-02-28
View more
  3 in total

1.  Clinicopathologic characteristics and outcomes of renal thrombotic microangiopathy in anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis.

Authors:  Su-Fang Chen; Huan Wang; Yi-Min Huang; Zhi-Ying Li; Su-Xia Wang; Feng Yu; Ming-Hui Zhao; Min Chen
Journal:  Clin J Am Soc Nephrol       Date:  2015-03-06       Impact factor: 8.237

2.  Pulmonary Limited MPO-ANCA Microscopic Polyangiitis and Idiopathic Lung Fibrosis in a Patient with a Diagnosis of IgA Nephropathy.

Authors:  Alwin Tilanus; Patricia Van der Niepen; Caroline Geers; Karl Martin Wissing
Journal:  Case Rep Nephrol       Date:  2015-07-22

3.  Extreme Thrombocytosis Presenting in Anti-Neutrophil Cytoplasmic Autoantibodies-Associated Crescentic Glomerulonephritis with Immune Complex Deposits: A Case Report.

Authors:  Zhang Xuemei; Diao Yongshu; Zhang Ling; Yang Yingying; Fu Ping
Journal:  Iran Red Crescent Med J       Date:  2016-04-25       Impact factor: 0.611

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.